Results 131 to 140 of about 210,208 (400)
Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang+3 more
wiley +1 more source
Abstract Aims Plasma volume status (PVS) is recognized as a marker of systemic congestion, but its clinical utility in patients with mitral regurgitation (MR) undergoing transcatheter edge‐to‐edge mitral valve repair (M‐TEER) has not been well established. This study aimed to evaluate the prognostic significance of PVS in these patients.
Ai Kagase+30 more
wiley +1 more source
Background Heart valve diseases affect over 100 million people globally, with mitral regurgitation being the most common in developed countries. Bioprosthetic heart valves, frequently used for replacement, typically last 10–15 years before degeneration ...
Yakup Alsancak+4 more
doaj +1 more source
Management of tricuspid regurgitation in patients undergoing mitral valve replacement for rheumatic mitral valve diseases [PDF]
BACKGROUND: In mitral valve diseases associated with long standing pulmonary hypertension,Tricuspid annulus dilates and fails to shorten during systole leading to Tricuspid regurgitation.Tricuspid regurgitation contributes to both the morbidity and ...
Prasanna, R
core
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang+18 more
wiley +1 more source
Rheumatic valve disease, a consequence of acute rheumatic fever, remains endemic in developing countries in the sub-Saharan region where it is the leading cause of heart failure and cardiovascular death, involving predominantly a young population.
Charles Mve Mvondo+6 more
doaj +1 more source
Abstract Background Transcatheter edge‐to‐edge repair (TEER) has been shown to be an effective treatment option for patients experiencing cardiogenic shock (CS) with concomitant high‐grade mitral valve regurgitation. However, haemodynamic changes following M‐TEER have not been thoroughly investigated. Afterload mismatch, leading to the deterioration of
Michal Droppa+8 more
wiley +1 more source
Prosthetic Replacement of the Mitral Valve [PDF]
Andrew G. Morrow+3 more
openalex +1 more source
Aortic valve replacement in neonates and infants: An analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database [PDF]
ObjectiveWe sought to describe early outcomes of aortic valve replacement in neonates and infants across a large multicenter cohort.MethodsNeonates and infants in the Society of Thoracic Surgeons Congenital Heart Surgery Database undergoing nontruncal ...
Austin, Erle H.+8 more
core +1 more source